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ABSTRACT  
Due to a limited range of immunoglobulin genes, cattle and several other domestic animals rely on 
postrecombinatorial amplification of the primary repertoire.  We report that activation-induced 
cytidine deaminase (AID) is strongly expressed in the fetal bovine ileal Peyer’s patch (IPP) and spleen 
but not in fetal bone marrow. The numbers of IGHV mutations correlate with AID expression. The 
mutational profile in the fetuses is similar to postnatal and immunised calves, with targeting of 
complementarity-determining region (CDR) over framework region (FR), preference of replacement 
over silent mutations in CDRs but not in FRs and targeting of the AID hotspot motif RGYW/WRCY. 
Statistical analysis indicates negative selection on FRs and positive selection on CDRs. Our results 
suggest that AID-mediated somatic hypermutation and selection take place in bovine fetuses, 
implying a role for AID in the diversification of the primary antibody repertoire in the absence of 
exogenous antigen.  
1 INTRODUCTION 
In comparison to mouse and man, lymphoid differentiation and somatic recombination in several 
domestic animals including rabbit, chicken and sheep yield a relatively small B cell pool with a 
restricted antibody repertoire1. In these latter species fetal and young animal gut-associated 
lymphoid tissue (GALT) hosts an actively proliferating population of B cells which generates the 
peripheral B cell pool and the final primary (pre- immune response) antibody repertoire2,3. In 
ruminants, the amplification of naïve B cells and primary repertoire expansion is thought to take 
place in the ileal Peyer’s patch (IPP)4,5. Somatic hypermutation (SHM) and gene conversion (GC) have 
been suggested to expand the limited antibody repertoire in ruminants after recombination but 
prior to encountering external antigens6–9, although evidence for GC in ruminants is not as strong as 
in rabbit10,11 or chicken12,13.  
SHM and GC are well-characterized as secondary diversification processes mediated by activation-
induced cytidine deaminase (AID) upon encountering an external antigen. AID attacks single-
stranded DNA during transcription and deaminates cytosines to uracils14. AID preferentially targets C 
residues in the third position in WRCY hot spot motifs (W = A/T, R = A/G, Y = C/T)15–18. If the resulting 
uracil is not recognized and removed by base excision or mismatch repair pathways, it may be used 
as a template during replication. The outcome is often a mutation regardless of the mechanism19–22. 
Mutations caused by AID activity are targeted to a region extending about 2 kb downstream from 
the immunoglobulin (Ig) promoter, including the VDJ coding exon and the J region intron23. In SHM, 
U:G mismatches recruit error-prone DNA repair machinery which increases the mutation rate by up 
to a million fold, as recently reviewed by Storck et al24. The number of mutations is significantly 
higher in the CDRs than in the FRs. Mutations in the CDRs enable the generation of high-affinity 
antibodies23,25.  
To our knowledge this is the first study in fetal ruminants that directly links AID to IPP or to primary 
antibody formation. mRNA expression of bovine AID and its mutagenic activity has been analysed in 
neonatal and adult lymphoid tissues although not in IPP9. In this paper, we demonstrate AID 
expression in bovine fetal IPP and also in fetal spleen prior to the exposure to exogenous antigens. 
The mutational profiles of immunoglobulin heavy chain variable (IGHV) genes in fetus are compared 
to those generated by antigen-induced AID-mediated somatic hypermutation.  
  
2 RESULTS 
2.1 AID is expressed in bovine fetal IPP and spleen 
The expression of AID mRNA was analysed by reverse transcription-qPCR (RT-qPCR) in fetal ileum, 
spleen, lymph node and bone marrow, with muscle as a negative control. The AID expression level 
(as mean of GAPDH-normalized cycle threshold values ± SD) was 11.0±3.8 in ileum (n=21),  9.9±3.3 in 
spleen (n=20),  12.8±2.3 in lymph node (n=16), 16.2±1.5 in bone marrow (n=14) and 16.5±3.7 in 
muscle (n=10). AID expression in ileum and spleen differed significantly from the expression in bone 
marrow and muscle, as assessed using nonparametric Kruskal-Wallis ANOVA (χ2=35.5, p<2·10-16) 
followed by multiple comparisons using Nemenyi-Damico-Wolfe-Dunn test at α=0.01. Looking at the 
lymphoid tissues at various stages of development, no statistically significant differences in AID 
expression were observed in any tissue, apart from the high level of expression in the adult lymph 
node (Figure 1).  
In ileum, immunohistochemistry showed strong positive staining for AID in the IPP B-cell follicles 
(Figure 2A-B).  The follicles were AID positive from the stage the follicles became detectable at 
approximately 195 gestation days (gd). In fetal lymph nodes, AID positive follicles were observed 
only occasionally (Figure 2C-D). In fetal spleen and bone marrow, the distribution of AID protein 
could not be reliably analysed due to nonspecific binding of the primary antibody to non-lymphoid 
cells. Adult lymph node was used as a positive control and displayed the characteristic germinal 
center staining pattern (not shown)26. 
To assess the level of B cell production in the various lymphoid tissues, we also performed double 
immunofluorescence staining for the B cell marker CD79α+ and for the proliferation marker Ki67 
antigen (Figure 2E-G).  CD79α+ B cells proliferate more actively in the fetal IPP (median 75% Ki67+; SD 
9.4%; n = 7) than in lymph nodes (cortical follicles; 9.0±6.7%; n = 7; p = 0.002) and spleen (15±10%; n 
= 9; p = 0.002).  
2.2 Fetal IGHV cDNAs show signs of hypermutation and selection, but the overall mutational 
load is lower than in postnatal animals 
In order to characterize the mutation patterns in fetal IGHV sequences, we constructed IGHV cDNA 
libraries from ileum, spleen and bone marrow of two fetuses (240 and 270 gd). To compare the 
naïve fetal antibody repertoire to that after secondary antibody responses, we also generated cDNA 
libraries from ileum of a 51-day old calf and from a peripheral lymph node of an immunised calf. The 
germline reference sequences were obtained from the available bovine genome sequencing data27 
and by sequencing the functional IGHV genes in four additional animals, to a total of 35 functional 
IGHV genes. The fetal cDNAs aligned to the FR1-FR3 region of the germline sequences with an 
average pairwise identity of 99.6%. For the 51-day calf and the immunized calf, the average 
identities were 97.4% and 92.4%.  
Mutation pattern characteristic of somatic hypermutation was observed in cDNAs derived from fetal 
IPP and spleen as well as from the postnatal samples, although fetal sequences contained fewer 
mutations (Figure 3 and Table 1). The total mutation load was 5-9 mutations per kilobase in fetal 
samples from IPP and spleen, 26/kb in the IPP of the 51-day calf and 80/kb in the lymph node of the 
2-year old immunised calf. The ratio of mutations in CDRs versus FRs was 5.6 in fetuses (average of 
all ileal and splenic samples), 6.7 in the 51-day calf and 3.4 in the immunised calf. The ratio of 
replacement over silent mutations was 3.3 in fetuses, 3.1 in the 51-day calf and 2.1 in the immunised 
calf. In fetal bone marrow, few mutations were observed, and the mutations were not concentrated 
in the CDR regions (Figure 3 and Table 1).  
  
Negative selection had occurred in FRs while positive selection had occurred in the CDRs in both 
fetus and calf datasets, based on statistical tests developed specifically to estimate selection in Ig 
sequences (Table 2)28,29. In bone marrow, selection could not be reliably analysed due to the small 
numbers of mutations.  
2.3 Fetal mutations correlate with AID expression and are targeted to well-characterized AID 
hotspot motifs  
In the fetal tissues analyzed (ileum, spleen and bone marrow at 240 and 270 gd), AID expression as 
measured by RT-qPCR correlated significantly and positively with the overall mutational load (r = 
0.922, p = 0.027, n = 6) and specifically with the numbers of CDR mutations (r = 0.946, p = 0.016) and 
missense mutations (r = 0.917, p = 0.027). AID expression also correlated with silent mutations (r = 
0.845, p = 0.034) which are not affected by selection on the protein level. 
AID is known to preferentially target WRCY and its complementary RGYW motif in the genome17,30. 
In particular, Cs at the third position of WRCY and the corresponding Gs at the second position of 
RGYW are targeted. We searched for these hotspot motifs at the FR1 to FR3 region and analysed 
mutations within the motifs. As shown in Figure 4, the target G/C nucleotides in RGYW/WRCY motifs 
were preferentially mutated as compared to G/C nucleotides outside the motifs in both fetal and 
postnatal calf sequences.  
3 DISCUSSION 
In ruminants, the fetal IPP is characterized by somatic hypermutation of Ig genes in the absence of 
an external antigen6. To our knowledge no molecular studies addressing the mechanism have been 
reported. We studied the role of AID in this process. AID is an obligatory factor in all known 
mechanisms which shape the antibody repertoire in response to antigenic challenge, e.g. SHM, GC 
and class switch recombination31–33.  
We report that AID is strongly expressed in fetal bovine IPP and spleen (Figures 1 & 2). The 
mutational profile in IGHV cDNA sequences derived from these tissues is similar to the profile 
generated by AID-mediated SHM in secondary antibody response. Mutations are preferentially 
located in CDRs (Figure 3), generally resulting in an amino acid change (Table 1), and are enriched in 
the AID hotspot motifs (Figure 4). In contrast, AID expression is low in fetal bone marrow, correlating 
with small numbers of IGHV mutations. The data are highly suggestive of AID-dependent SHM in 
fetal bovine IPP and spleen prior to exposure to exogenous antigens, and imply a specific molecular 
mechanism to diversify the limited germline Ig repertoire34,27.  
Statistical analysis indicated strong selection of the mutated IGHV sequences in fetal IPP and spleen 
(Table 2). Negative selection on the FRs can be explained by the adverse effects replacement 
mutations have on protein structure. The CDR sequences were positively selected, although the 
fetus is sterile and there is no appreciable external antigen present to account for the selective 
forces. In sequences derived from fetal IPP and spleen, mutations were ~5.6 times as frequent in 
CDRs as in FRs. The RGYW/WRCY preference of AID explains at most about 34% of this difference, as 
the frequency of these motifs in CDRs was ~1.9 times that in FRs. The remainder can be attributed to 
selection, although other components of the mutation machinery may also contribute, such as the 
WA/TW mutator DNA polymerase η recruited by AID-induced U:G mismatches17,30,35. The positive 
selection may be driven by unknown endogenous antigen(s). Even if not antigen driven, the products 
of unmutated IGHV genes may be unable to provide for proliferative signals as efficiently as those 
encoded by genes carrying favourable mutations in their CDR-encoding regions. 
  
Unknown IGHV germline sequences potentially present in the analysed animals or technical 
sequence errors did not likely affect our conclusions. To complement the limited information on the 
structure of the bovine Ig heavy chain locus, we recently characterized the bovine IGHV repertoire 
based on the available genome sequencing data27. In addition, we now cloned and sequenced 
functional IGHV genes in individual animals analysed in this work. To improve the accuracy of cDNA 
datasets, short or low quality cDNA sequences were excluded from the analyses. The combined error 
rate for PCR and sequencing, based on analysis of the vector-derived sequences, was 0.784 per kb or 
about 5% of the average observed mutational load. We also tested for the generation of chimeric 
IGHV sequences in the PCR reactions, using a 1:1 mixture of two known IGHV clones.  We cloned and 
sequenced 109 PCR products out of which only one clone was chimeric, indicating that the 
polymerase used was highly processive. 
The bovine genome contains a limited number of functional immunoglobulin genes which are 
restricted to few families or subgroups34,27. Antibody diversifying mechanisms in addition to 
recombination are therefore likely to exist. Previous studies have suggested that these may include 
SHM6,36, GC7 and junctional diversity37. Our study provides extensive molecular and mutational data 
suggesting that AID-associated SHM and selection are taking place in the IPP and spleen of bovine 
fetuses before exposure to external antigens. These processes are apparently spatially separated 
from de novo B lymphopoiesis and RAG-mediated recombination which occur in the fetal bovine 
bone marrow and lymph nodes38,39, as AID expression and/or the numbers of IGHV  mutations are 
low in these tissues.  
Using hematopoietic chimeras, we have previously shown that peripheral B lymphocytes in young 
cattle are generated from a self-sufficient pool of developing B cells independent of bone marrow 
hematopoietic stem cells40. In these animals, the ratio of donor cells among circulating B 
lymphocytes stably reflected that in the IPP. These observations and our current data suggest two 
phases of B cell generation: first, differentiation in bone marrow and lymph nodes; second, 
migration to the IPP for additional diversification of the limited germline repertoire by SHM. In 
addition to IPP, SHM in cattle fetuses occurs in spleen, and occasional AID-positive follicles were also 
observed in fetal lymph nodes (Fig. 2C-D). The proliferation rate of B cells is markedly higher in the 
IPP than in the other lymphoid tissues (Fig. 2E-G)41, whereas the total number of lymphocytes in IPP 
is roughly comparable to spleen and lymph nodes42,43. Thus, our observations are compatible with 
previous studies indicating that IPP produces the majority of the diversified peripheral B cell pool44. 
4 METHODS 
4.1 RNA extraction 
Tissue samples from 15 bovine fetuses (190 to 290 gd) were collected from a local abattoir, snap 
frozen in liquid nitrogen and conserved at -80°C. Total RNA was extracted from ileum, spleen, lymph 
node, bone marrow, and muscle using Eurozol (EuroClone, Milano, Italy) according to 
manufacturer’s instructions. Briefly, 100-300 mg of frozen tissue was ground in a pre-cooled mortar, 
suspended in 1 ml Eurozol and homogenized using Polytron PT1200 homogenizer (Kinematica AB, 
Lucerne, Switzerland). 2.5 M lithium chloride was used to precipitate RNA followed by resuspension 
in RNase-free water. Remaining genomic DNA was removed with DNase treatment (Turbo DNase, 
Life technologies, Grand Island, NY) according to manufacturer’s instructions. The RNA concentration 
was determined on Nanodrop spectrophotometer (Thermo Scientific, Asheville, NC) and the quality 
was assessed using RNA 6000 Nano kit on Agilent 2100 Bioanalyser (Agilent Technologies, Santa 
Clara, CA). 
  
4.2 Reverse transcription-qPCR 
First-strand cDNA was synthesized from 1 µg of DNase-treated total RNA using RevertAid M-MuLV 
Reverse Transcriptase (Fermentas, St. Leon-Rot, Germany). cDNAs were prepared as previously 
described38. The cDNA mixture was diluted 1:2 in RNase-free water and 2 µl of this was used as a 
template in the qPCR reaction. 
qPCR was performed using the SYBR green technology. The primers, bAIDfw3, bAIDrev2 and 
QGAPDfw, QGAPDrev (Table 3) were designed on the basis of known sequences of bovine AID and 
bovine glyceraldehyde-3-phosphate dehydrogenase (GeneBank accession number NM_001038682.1 
(AID) and NM_001034034.1 (GAPDH)). Each reaction contained 1× SYBR Premix Ex Taq mixture 
(TaKaRa, Otsu, Japan), 0.2 µM of forward and reverse primers and 1× ROX II Reference Dye in a final 
volume of 20 µl. PCR conditions were adjusted with serial dilutions (107-101) of plasmid templates 
confirming that the PCR efficiency was satisfactory (90-110%). Templates used in these standard 
curves were cloned into pBluescript II SK (AID) vector (Fermentas) and pSTBlue-1 (GAPDH) vector 
(Life technologies). The cDNA was transcribed from total RNA obtained from a young calf. The 
cloning primers were Aicda 5’ and Aicda 3’  yielding a 651 bp product (AID) and  QGAPDfw and 
QGAPDrev yielding a 145 bp product (GAPDH) (Table 3). Amplicons from the templates and cDNA 
samples were sequenced. Amplification was carried out using Stratagene’s Mx3005P real-time PCR 
system (Agilent Technologies). Cycling conditions were: 95°C for 10 s, followed by 40 cycles of 95°C 
for 5 s, 60°C for 35 s and 80°C for 15 s. The fluorescence signal was collected at 80°C, with two 
replicates per each sample. The dissociation curves of the final products were analysed with 
following conditions: 95°C for 60 s, 55°C for 30 s and 95°C for 30 s, where the data was collected 
during all points from 55°C to 95°C. 
Cycle threshold (Ct) values were determined with MxPro software based on a threshold line that was 
automatically defined above the non-informative data. To control the possible variation in the 
amount of cDNA in different samples, the level of gene expression of the target genes was 
normalized in relation to the reference gene GAPDH.  
4.3 Immunostaining 
AID immunohistochemistry was performed using the anti- human AID monoclonal antibody EK2-5G9 
(Ascenion, Munich, Germany)26. The immunogenic peptide sequence of the anti-AID antibody is 
100% identical to the bovine AID, and it produced an expected staining pattern in adult lymph nodes 
used as positive controls. Paraffin sections of paraformaldehyde-fixed tissues were subjected to 
heat-induced antigen retrieval in 10 mM Tris-HCl pH 9.5, 1 mM EDTA pH 8.0 and blocked for 
endogenous peroxidase and biotin. The primary antibody was detected using a biotinylated goat 
anti-ratIg secondary antibody (Jackson Immunoresearch, Suffolk, UK) and tyramide signal 
amplification as described previously45.  
Double immunofluorescence for CD79α and the Ki67 antigen was performed using the mouse anti- 
human CD79α monoclonal antibody HM57 (Dako, Glostrup, Denmark) and the rabbit anti- human 
Ki67 antigen monoclonal antibody SP6 (Thermo Scientific, Asheville, NC). Antigen retrieval was 
performed as above. The primary antibodies were detected using an Alexa Fluor 488 conjugated 
goat anti-mouseIg secondary antibody and an Alexa Fluor 546 conjugated goat anti-rabbitIg 
secondary antibody (Life Technologies). The sections were counterstained with DAPI and the 
formaldehyde-induced autofluorescence was suppressed by staining in 0.1% Sudan Black B in 70% 
ethanol for 20 minutes. 
The immunostained sections were observed and photographed using a Leica DM4000 microscope 
(Leica Microsystems, Wetzlar, Germany) equipped with an Olympus DP70 (Olympus, Tokyo, Japan) 
  
camera. CD79α single positive and CD79α/Ki67 double positive cells were counted using the ImageJ 
software46.  
4.4 Preparation and sequencing of fetal and calf IGHV cDNA libraries 
Samples of ileum were collected from fetuses of 240 and 270 gd and from a 51 days old calf. Spleen 
and bone marrow samples were also collected from the fetuses. First-strand cDNA was synthesised 
using SuperScript III First-Strand Synthesis SuperMix (Life technologies) according to manufacturer’s 
instructions. cDNA was primed with target specific primers (IgH rev1 for ileum of 240 days old fetus), 
or with equal amounts of oligo(dT)20 and random primer mixes for the rest of the samples. Phusion 
High-Fidelity PCR master mix (Thermo Scientific) was used for PCR. Reaction contained 1× Phusion 
master mix and 0.5 µM of forward and reverse primers (IgH fwd1 and IgH rev1 for samples from 
ileum and IgH fwd2 and IgH rev2 for samples from spleen and bone marrow, Table 3) in a final 
volume of 50 µl. Primers were designed to span the IGHV region from leader sequence to IGHµ 
region. 2 µl of first-strand cDNA was used as the template. Cycling conditions consisted of an initial 
denaturation of 98°C for 30 s, followed by 18 cycles of 98°C for 10 s, 60°C for 30 s, 72°C for 20 s and 
a final extension of 72°C for 7 min. PCR products were then electrophoresed and purified. 
Approximately 100 ng of the purified PCR product was ligated into the pCR 4Blunt-TOPO vector and 
transformed into TOP10 E. coli (Life technologies). The TOP10 E. coli were grown overnight at 37°C 
on LB-ampicillin (100 µg/ml) plates.1 ml of LB-ampicillin medium was inoculated with a single 
bacterial clone.  
For the 240 gd ileum, a total number of 384 single clones were isolated for sequencing.  Purified 
DNA was amplified for 35 cycles using Dynazyme II polymerase (Thermo Scientific) with T7 and T3 
primers (Oligomer, Helsinki, Finland). The PCR products were sequenced at the DNA sequencing and 
Genomics laboratory (Institute of Biotechnology, University of Helsinki, Finland).  
For the rest of the samples, 48-144 single colonies were picked, purified and sequenced. Plasmid 
purification and sequencing was conducted by GATC Biotech AG (Konstanz, Germany). 
4.5 Preparation and sequencing of a post-immunisation IGHV cDNA library 
An inactivated whole-cell Streptococcus uberis vaccine was used for vaccination of a calf which 
developed a strong antibody response. The draining lymph node of the vaccination site was removed 
at slaughter 9 months after vaccination, cut into small pieces and stored in RNAlater (Ambion). Total 
RNA was extracted from the lymph node using Trizol (Invitrogen) according to the manufacturer’s 
instructions. RNA was DNase treated (DNase I Recombinant, Roche) and first-strand cDNA 
synthesised using the iScript Select cDNA synthesis kit (BioRad) with equivalent concentrations of 
the Oligo(dT)20 and random primer mixes. The bovine VH repertoire was amplified in PCR reactions 
containing 20 ng cDNA, 0.5 µM of each of 3 reverse primers (Bov VH-R1 – Bov VH-R3, Table 3) in 
combination with 0.5 µM of each of one of 8 forward primers (Bov VH-F1 – Bov VH-F8), 0.2 µM each 
dNTP, 2.5 mM MgCl2, 0.05 U Platinum Taq DNA Polymerase (Invitrogen) and 1x PCR buffer in a final 
volume of 20 µl. Cycling conditions were: 95oC for 10 min, followed by 30 cycles of 94oC for 30 s, 
55oC for 30 s and 72oC for 45 s followed by a final 10 min extension at 72oC. The 8 heavy chain 
reactions were combined and column purified using the DNA Clean and Concentrator kit (Zymo 
Research) prior to digestion with AscI and SpeI. The digested DNA was ligated into the similarly 
digested vector JSC (GenBank Accession EU109715). DH5-E ElectroMax (Invitrogen) were 
transformed with the ligated DNA and plated on 2YT-amp plates (100 ug/ml ampicillin) containing 
2% glucose. There were 4.3 ∙ 1010 primary transformants of which 88% contained an insert. A total of 
384 clones were isolated from the library for sequencing using primers specific to plasmid JSC 
(JSCmcsFwd  and JSCmcsRev1, Table 3) and analysed as above.  
  
4.6 Cloning and sequencing of bovine germline IGHV genes 
Muscle genomic DNA was extracted from three fetuses (aged 182, 240 and 270 gd) and a 51 days old 
calf using GenElute Mammalian genomic DNA Miniprep kit (Sigma-Aldrich, St. Louis, MO, USA). 
Primers GenIGHV fwd1 and GenIGHVrev1 (Table 3) were used with Phusion High –Fidelity PCR 
master mix. Purified PCR product was then cloned into pCR 4 Blunt-TOPO vector as above. A total 
number of 384 colonies was picked, purified and sequenced by GATC Biotech AG, yielding 35-70 
sequences per animal. Sequences that were observed at least twice were accepted, to a total of 214 
reads. 
4.7 Analysis of mutations 
The sequence data from the cDNA libraries was analysed with Geneious Pro software version 5.6.6 
(Biomatters, New Zealand) and R47. High-quality cDNA sequences spanning the FR1-FR3 region were 
matched to the bovine IGHV gene sequences and aligned on the best matching genes using the 
“map to reference” function of Geneious with high sensitivity. Replacement and silent mutations in 
the cDNA alignments and specifically in the AID target motifs WRCY/RGYW17,30 in the IGHV genes 
were detected in Geneious. WRCY and RGYW target motifs were detected separately in the forward 
strand. The numbers of mutations in FR and CDR regions, mutations of the AID target nucleotides 
(the third C in motif WRCY and the second G in motif RGYW) and mutations of G/C nucleotides 
outside the AID motifs were counted in R47. The ratios of mutated FR/CDR/AID target/non-target 
nucleotides were then calculated as  
      ∑  
 
   
∑  
 
   
⁄   
where mi = the number of mutated FR/CDR/AID target/non-target nucleotides in the i
th cDNA 
sequence, ni = the total number of FR/CDR/AID target/non-target nucleotides in the corresponding 
reference gene sequence, and k = the number of cDNA /reference gene sequence pairs analysed 
from the tissue sample.  
4.8 Statistical analysis 
RT-qPCR data from different fetal tissues were compared in R using the nonparametric approximate 
Kruskal-Wallis One-way ANOVA followed by multiple comparisons using the nonparametric 
Nemenyi-Damico-Wolfe-Dunn test at α=0.01.   
Cell counts from immunofluorescence analyses were compared using the nonparametric Mann-
Whitney U test in the IBM SPSS Statistics software version 20 (IBM Corporation). 
For detecting selection, the BASELINe framework (Bayesian estimation of antigen-driven selection)  
was applied28,29. The tests were run at the web server at http://selection.med.yale.edu/baseline/ 
using focused selection statistics and CDR and FR boundaries as defined by Kabat et al48.  
The Pearson correlations between AID expression data and the mutation counts were calculated in 
IBM SPSS Statistics version 20. 
P values for cell counts and correlations were corrected for multiple testing using Holm’s method49. 
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TABLE AND FIGURE LEGENDS 
Table 1. Replacement and silent mutations in the FR1-FR3 regions of bovine IGHV sequences. 
Numbers [replacement/silent (ratio)] are shown per 1 kb CDR/FR sequence analysed and represent 
weighted averages between the cDNA sequence groups aligned to each gene.  n = number of high-
quality cDNA sequences analysed.  
Sample n CDR FR CDR/FR 
fetal ileum, 240 gd 326 9.6/1.5 (6.2) 1.6/1.5 (1.1) 5.9/1.0 (5.7) 
fetal ileum, 270 gd 136 15/1.6 (9.7) 1.2/1.1 (1.0) 13/1.4 (9.4) 
fetal spleen, 240 gd 43 13/0 1.3/1.5 (0.9) 9.6/0 
fetal spleen, 270 gd 44 25/2.2 (12) 2.5/1.7 (1.4) 10 /1.2 (8.1) 
fetal bone marrow, 240 gd 101 2.1/0 0.8/0.5 (1.5) 2.6/0 
fetal bone marrow, 270 gd 52 0/0 1.3/0.8 (1.6) 0/0 
calf ileum, 51 d 70 66/11 (6.1) 6.5/5.2 (1.3) 10/2.1 (4.9) 
calf lymph node, 2 years, immunised 302 130/42 (3.1) 31/21 (1.5) 4.2/2.0 (2.1) 
 
  
  
Table 2. Assessing selection in bovine IGHV sequences. Combined Σ and P-values for all cDNA 
sequences are indicated28,29. Σ is a quantitative measure of selection. Positive and negative values 
indicate positive and negative selection, respectively.  
Sample 
 
Σ P 
CDR FR CDR FR 
fetal ileum, 240 gd 1.11 -0.859 2.25 · 10-10 -2.25 · 10-5 
fetal ileum, 270 gd 1.22 -1.13 4.13 · 10-7 -2.77·10-4 
fetal spleen, 240 gd 2.21 -0.644 3.06 · 10-4 -0,158 
fetal spleen, 270 gd 1.08 -0.515 1.48 · 10-3 -0.121 
fetal bone marrow, 240 gd 1.47 0.226 0.0192 0.401 
fetal bone marrow, 270 gd -2.15 -0.962 -0.0218 -0.155 
calf ileum, 51 d 1.29 -0.593 1.3 · 10-13 -0.0047 
calf lymph node, 2 years, immunised 0.415 -0.618 2.72·10-14 -1.23·10-14 
 
 
  
  
Table 3. PCR primers. 
Primer Sequence 5'→3' 
bAIDfw3 GGAGTCCAGATCGCCATC 
bAIDrev2 GCAAGTCATCAACCTCGTAG 
QGAPDfw CTGACCTGCCGCCTGGAG 
QGAPDrev AAGAGTGAGTGTCGCTGTTGAAG 
Aicda 5’ AAAAGGATCCGAACTGGATTCCACCATGGACAGCC 
Aicda 3’ TTTGAATTCTTCTTGAAGGTTGGTATCAAAGTCCC 
JSCmcsFwd GTGTGGAATTGTGAGCGGAT 
JSCmcsRev1 CGTCTTTCCAGACGTTAGTA 
IgH fwd1 TTGTGCTSTCAGCCCCCAGA 
IgH rev1  CGCAGGACACCAGGGGGAAG 
IgH fwd2 ACCCAYTGTGGACCCTCCTCT 
IgH rev2 ACTGAATTGGGCACGAAGTCCCG 
Gen IGHVfwd1 GGAGTGGTGACTYTCATCTGCT 
Gen IGHVrev1 TTTTGTCTGGGCTCACACTG 
T7 TAATACGACTCACTATAGGG 
T3 ATTAACCCTCACTAAAGGGA 
Bov VH-F1 GATCGGCGCGCCADGTGCADCTGCGCGAGTYGG 
Bov VH-F2 GATCGGCGCGCCAGRTGMAGTGYGGGGARTCA 
Bov VH-F3 GATCGGCGCGCCAGGTGSASYTGCGGGAGTCA 
Bov VH-F4 GATCGGCGCGCCRGGTGCWGCTGCGSGAGTCYGG 
Bov VH-F5 GATCGGCGCGCCAGCTGGAGCTACRGGAGTCG 
Bov VH-F6 GATCGGCGCGCCAGGTGCRHYTGCGGGAGTCG 
 
  
  
Figure 1. AID mRNA expression analysed by RT-qPCR. Negatives of GADPH-normalized cycle 
threshold values (–ΔCt, mean ± SD) are shown in bone marrow, lymph node, ileum and spleen for 
three fetal stages and for adults. The dashed lines represent mean ± SD of AID expression in muscle 
used as the negative control (N=12).  
  
  
Figure 2. AID expression and B lymphocyte proliferation in fetal bovine lymphoid tissues. A: AID 
expression in the ileum of a 238 gd fetus. B: higher magnification of the area indicated by the box. C: 
AID expression in the lymph node of a 250 gd fetus. D: higher magnification of the area indicated by 
the box. E-G: Double immunofluorescence for the B cell marker CD79α (green) and the proliferation 
marker Ki67 antigen (red) in the ileum of a 260 gd fetus (E), in a lymph node of a 250 gd fetus (F) and 
in the spleen of a 227 gd fetus (G). Bars = 100 µm. 
  
  
 
Figure 3. Mutational loads in FR and CDR regions of IGHV cDNA sequences from fetal and calf 
lymphoid tissues. Bars represent mutations per 1 kb FR or CDR sequence analysed. No CDR 
mutations were observed in the bone marrow of the 270-day fetus. For numbers of cDNA sequences 
analysed see Table 1.   
Figure 4. Targeting of mutations to AID hotspot motifs (RGYW/WRCY) in IGHV cDNA sequences from 
fetal and calf lymphoid tissues.  Numbers of mutated AID target G/C nucleotides and numbers of 
mutated G/C nucleotides outside AID target motifs are shown per 1000 target and non-motif G/C 
nucleotides analysed. A total of 11039 target G nucleotides, 10931 target C nucleotides, 63078 non-
target G nucleotides and 68486 non-target C nucleotides was analyzed. 
 
